Immunotherapy and Cancer Harnessing the Power 3 | A MESSAGE FROM MOLECULARMD Immuno-oncology's century-old promise now bearing fruit 5 | FEATURE Achieving the Full Potential of Immuno-Oncology Harnessing the innate power of the human immune system of Diagnostic Assays 11 | THE EVOLUTION OF CANCER THERAPIES AND BIOMARKERS 12 | Q&A with Cindy Spittle, Ph.D. Precise molecular tests are crucial to the clinical success of an immuno-oncology candidate. 15 | NEWS Biomarker Identification via NGS in the Age of Immunotherapies Taking a test from research use only Sponsored by to clinical diagnostic 18 | POSTERS Photo credits: Getty Images: cover and p. 2: (background) Seb Oliver; (insets) Science Photo Library: Moredun Animal Health Ltd., Alfred Pasieka, Steve Gschmeissner; p. 2 & 5: D3Damon; p. 2, 14,15, 16: Jezperklauzen; p. 7: jarun011; p. 8 selvanegra; p. 9: Science Photo Library/Alfred Pasieka. Adobe Stock Photos: p. 17: sveta. Deposit Photos: p. 3: ktsdesign. Sue Seif: p. 7: from Shannon L. Maude et al. Blood 2015;125:4017-4023. 2 A Clinical OMICs eBook www.clinicalomics.comhttps://clinicalomics.com/ http://molecularmd.com/ http://www.clinicalomics.com